Luca Di Leo
8PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 07, 2025
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.Anamarija Pfeiffer, Luca Di Leo, Marc Baker Bechmann
|Jun 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.Luca Di Leo, Chiara Pagliuca, Ali Kishk
|Jul 26, 2023
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.Tamara Bintener, Maria Pires Pacheco, Demetra Philippidou
|Mar 03, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.Alex Frias, Luca Di Leo, Asier Antoranz
|Dec 23, 2022
New Insights into the Phenotype Switching of Melanoma.Chiara Pagliuca, Luca Di Leo, Daniela De Zio
|Oct 15, 2022
The Cancermuts software package for the prioritization of missense cancer variants: a case study of AMBRA1 in melanoma.Matteo Tiberti, Luca Di Leo, Mette Vixø Vistesen
Pageof 2
Frequent Collaborators
7 joint publications
Daniela De Zio
3 joint publications
Salvatore Rizza
3 joint publications
Francesco Cecconi
3 joint publications
Giuseppe Filomeni
2 joint publications
Thomas Sauter
2 joint publications
Chiara Pagliuca
2 joint publications
Matteo Bordi
2 joint publications
Rosalie C Sears
1 joint publications
Giacomo Milletti
1 joint publications
Daniele Simoneschi
